Structure-based Drug Design Benchmark: Do 3D Methods Really Dominate?

Structure-based Drug Design Benchmark: Do 3D Methods Really Dominate?

4 June 2024

Yingzhou Lu

Papers citing "Structure-based Drug Design Benchmark: Do 3D Methods Really Dominate?"

7 / 7 papers shown

Title
TransDiffSBDD: Causality-Aware Multi-Modal Structure-Based Drug Design Xiuyuan Hu Guoqing Liu Can Chen Yang Zhao Hao Zhang Xue Liu 42 2 0 26 Mar 2025
DeepProtein: Deep Learning Library and Benchmark for Protein Sequence Learning Jiaqing Xie Yue Zhao 28 0 0 02 Oct 2024
D2O: Dynamic Discriminative Operations for Efficient Long-Context Inference of Large Language Models Zhongwei Wan Xinjian Wu Yu Zhang Yi Xin Chaofan Tao ... Xin Wang Siqi Luo Jing Xiong Mi Zhang Mi Zhang 14 0 0 18 Jun 2024
MEIT: Multi-Modal Electrocardiogram Instruction Tuning on Large Language Models for Report Generation Zhongwei Wan Che Liu Xin Wang Chaofan Tao Hui Shen Zhenwu Peng Jie Fu Rossella Arcucci Huaxiu Yao Mi Zhang 32 1 0 07 Mar 2024
A 3D Generative Model for Structure-Based Drug Design Shitong Luo Jiaqi Guan Jianzhu Ma Jian-wei Peng DiffM 60 176 0 20 Mar 2022
Accelerating high-throughput virtual screening through molecular pool-based active learning David E. Graff E. Shakhnovich Connor W. Coley 64 139 0 13 Dec 2020
Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models Daniil Polykovskiy Alexander Zhebrak Benjamín Sánchez-Lengeling Sergey Golovanov Oktai Tatanov ... Simon Johansson Hongming Chen Sergey I. Nikolenko Alán Aspuru-Guzik Alex Zhavoronkov ELM 154 628 0 29 Nov 2018